サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467874

血漿分画市場レポート：製品、セクター、用途、エンドユーザー、地域別、2024～2032年

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血漿分画市場レポート：製品、セクター、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿分画市場規模は2023年に251億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに397億米ドルに達し、2024～2032年の間に5.1％の成長率（CAGR）を示すと予測しています。

血漿分画とは、提供された血漿を下流工程で処理し、救命治療や医薬品にすることです。遠心分離、深層濾過、沈殿、クロマトグラフィーなどの機械的分離法を用いて、血漿を個々のタンパク質または血漿分画に分画します。現在では、アルコール濃度、時間、温度、pHを利用して、特定の治療用タンパク質を抽出する最新の分画法がいくつかあります。さらに、長年にわたる技術の複雑化と工程内でのウイルス減少処理の採用は、新しいタンパク質治療の開発と製品の純度と品質の向上をもたらしました。

血漿分画市場の動向：

ヒト血漿から分画されるタンパク質製品は、感染症、先天性欠損症、希少血液疾患、免疫疾患、自己免疫疾患など、生命を脅かす疾患の予防、管理、治療に広く使用される重要な治療です。世界的に、人口のかなりの部分でこれらの疾患の有病率が大幅に上昇していることが、市場成長を促す重要な要因の一つとなっています。さらに、生物学的製剤の品質保証に関する各国の管理機関による厳格な規制や標準管理・設定の実施により、メーカーはさらなる安全性を備えた血漿分画を開発しています。これとは別に、市場各社は研究開発（R&D）活動に資金を提供し、製品の有効性を向上させ、免疫グロブリンG（IgG）の回収率を高めて新たな血漿タンパク質を分離するための血漿製造技術の進歩を打ち出しています。さらに、地域の血漿資源を安全に利用できるよう、手頃な価格のウイルス不活化・処理技術の開発にも注力しています。このことは、収率の向上、プロセス経済性の維持、規制要件の増加に対処する必要性の高まりと相まって、今後数年間は良好な市場展望をもたらすと予想されます。

本レポートで扱う主要質問

  • 2023年の血漿分画の世界市場規模は？
  • 2024～2032年の世界の血漿分画市場の予想成長率は？
  • COVID-19が血漿分画の世界市場に与えた影響は？
  • 血漿分画の世界市場を牽引する主要因は？
  • 血漿分画の世界市場における製品別の区分は？
  • 血漿分画の世界市場のセクター別区分は？
  • 血漿分画の世界市場の用途別区分は？
  • エンドユーザー別の血漿分画の世界市場の内訳は？
  • 血漿分画の世界市場における主要地域は？
  • 血漿分画の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 血漿分画の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 免疫グロブリン
  • アルブミン
  • 凝固第VIII因子
  • 凝固第IX因子

第7章 市場内訳：セクター別

  • 民間
  • 公共

第8章 市場内訳：用途別

  • 神経セグメント
  • 免疫学
  • 血液学
  • その他のアプリケーション

第9章 市場内訳：エンドユーザー別

  • 病院・クリニック
  • 臨床研究所
  • 学術機関

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ADMA Biologics
    • Bio Products Laboratory Ltd.
    • Boccard
    • Grifols, S.A.
    • Hemarus Therapeutics Limited
    • Intas Pharmaceuticals Limited
    • LFB S.A.
    • Merck Group
    • Octapharma AG
    • PlasmaGen BioSciences Pvt. Ltd.
    • SK Plasma Co. Ltd.
    • Virchow Biotech Private Limited
図表

List of Figures

  • Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
  • Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2023
  • Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
  • Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
  • Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million US$), 2024-2032
  • Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Plasma Fractionation Market: Competitive Structure
  • Table 8: Global: Plasma Fractionation Market: Key Players
目次
Product Code: SR112024A5973

The global plasma fractionation market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sector, application and end user.

Breakup by Product:

Immunoglobulins

Albumin

Coagulation factor VIII

Coagulation factor IX

Breakup by Sector:

Private Sector

Public Sector

Breakup by Application:

Neurology

Immunology

Hematology

Other Applications

Breakup by End User:

Hospitals and Clinics

Clinical Research Laboratories

Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global plasma fractionation market in 2023?
  • 2. What is the expected growth rate of the global plasma fractionation market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global plasma fractionation market?
  • 4. What are the key factors driving the global plasma fractionation market?
  • 5. What is the breakup of the global plasma fractionation market based on the product?
  • 6. What is the breakup of the global plasma fractionation market based on the sector?
  • 7. What is the breakup of the global plasma fractionation market based on the application?
  • 8. What is the breakup of the global plasma fractionation market based on the end user?
  • 9. What are the key regions in the global plasma fractionation market?
  • 10. Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coagulation factor VIII
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Coagulation factor IX
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Public Sector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Other Applications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ADMA Biologics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bio Products Laboratory Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boccard
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Grifols, S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hemarus Therapeutics Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Intas Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 LFB S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck Group
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Octapharma AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 SK Plasma Co. Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Virchow Biotech Private Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio